Literature DB >> 31302644

Positive Treatment Expectancies Reduce Clinical Pain and Perceived Limitations in Movement Ability Despite Increased Experimental Pain: A Randomized Controlled Trial on Sham Opioid Infusion in Patients with Chronic Back Pain.

Julia Schmitz1, Maike Müller2, Jan Stork1, Iris Eichler1, Christian Zöllner1, Herta Flor3, Regine Klinger4.   

Abstract

BACKGROUND: Increasing evidence for the efficacy of analgesic placebo effects in laboratory studies with healthy persons raises the question whether placebos could be used to improve the treatment of pain patients. Expectancies play a central role in shaping analgesic placebo but also nocebo effects.
OBJECTIVES: We investigated to what extent a sham opioid infusion (saline solution) produces sustained clinically relevant placebo and nocebo effects in chronic back pain patients.
METHODS: Fifty-nine patients received the sham opioid infusion applied via a large drain dressing and were compared to 14 control patients without intervention (natural history, NH) while experimental pain stimuli were applied. All subjects were told that the infusion would decrease pain although in rare cases pain increase would be possible (induction of expectancy). In addition, conditioning was introduced where the participants either experienced a decrease in experimental pain (n = 17; placebo conditioning), an increase (n = 21; nocebo conditioning), or no change (n = 21, no conditioning).
RESULTS: Compared to the NH group, all infusion groups showed positive treatment expectancies and significantly (p < 0.001) reduced clinical back pain (primary outcome) and pain-related disability (secondary outcome, assessed by self-reported functional capacity and perceived impairment of mobility). Even the nocebo conditioned group experiencing increased experimental pain developed positive treatment expectancies followed by reduced pain experience. Positive treatment expectancies and relief in clinical back pain were significantly positively correlated (r = 0.72, p < 0.01).
CONCLUSIONS: These findings suggest that it may be beneficial to explicitly shape and integrate treatment expectancies into clinical pain management.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic back pain; Placebo/nocebo effects; Randomized controlled clinical trial; Sham opioid infusion; Treatment expectancies

Mesh:

Substances:

Year:  2019        PMID: 31302644     DOI: 10.1159/000501385

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  10 in total

1.  Prior Therapeutic Experiences, Not Expectation Ratings, Predict Placebo Effects: An Experimental Study in Chronic Pain and Healthy Participants.

Authors:  Luana Colloca; Titilola Akintola; Nathaniel R Haycock; Maxie Blasini; Sharon Thomas; Jane Phillips; Nicole Corsi; Lieven A Schenk; Yang Wang
Journal:  Psychother Psychosom       Date:  2020-06-03       Impact factor: 17.659

2.  Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients.

Authors:  Michael H Bernstein; Molly Magill; Arnold-Peter Weiss; Ted J Kaptchuk; Charlotte Blease; Irving Kirsch; Josiah D Rich; Sara J Becker; Steven Mach; Francesca L Beaudoin
Journal:  Psychother Psychosom       Date:  2019-09-27       Impact factor: 17.659

Review 3.  [Treatment expectations for postoperative pain].

Authors:  Julia Stuhlreyer; Regine Klinger
Journal:  Schmerz       Date:  2021-08-30       Impact factor: 1.629

Review 4.  [Neurobiological and neurochemical mechanisms of placebo analgesia].

Authors:  Livia Asan; Ulrike Bingel; Angelika Kunkel
Journal:  Schmerz       Date:  2022-03-17       Impact factor: 1.629

5.  Optimising treatment expectations in chronic lower back pain through observing others: a study protocol for a randomised clinical trial.

Authors:  Julia Stuhlreyer; Marie Schwartz; Till Friedheim; Christian Zöllner; Regine Klinger
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

Review 6.  Impact of contextual factors on patient outcomes following conservative low back pain treatment: systematic review.

Authors:  Carol Clark; Clare Killingback; Dave Newell; Bronwyn Sherriff
Journal:  Chiropr Man Therap       Date:  2022-04-21

Review 7.  [Systemic inflammation, "sickness behavior" and expectations : What role do expectations play in inflammation-associated symptoms?]

Authors:  Justine Schmidt; Johanna Reinold; Regine Klinger; Sven Benson
Journal:  Schmerz       Date:  2021-10-29       Impact factor: 1.629

Review 8.  [Seeing others is believing-analgesic placebo effects through observational learning?]

Authors:  Marie Schwartz; J Stuhlreyer; R Klinger
Journal:  Schmerz       Date:  2022-04-13       Impact factor: 1.629

9.  Observing treatment outcomes in other patients can elicit augmented placebo effects on pain treatment: a double-blinded randomized clinical trial with patients with chronic low back pain.

Authors:  Marie Schwartz; Laura-Marie Fischer; Corinna Bläute; Jan Stork; Luana Colloca; Christian Zöllner; Regine Klinger
Journal:  Pain       Date:  2021-12-17       Impact factor: 7.926

10.  Persistent SOMAtic symptoms ACROSS diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211).

Authors:  Meike Shedden-Mora; Anne Toussaint; Bernd Löwe; Viola Andresen; Omer Van den Bergh; Tobias B Huber; Olaf von dem Knesebeck; Ansgar W Lohse; Yvonne Nestoriuc; Gudrun Schneider; Stefan W Schneider; Christoph Schramm; Sonja Ständer; Eik Vettorazzi; Antonia Zapf
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.